Also, no other synaptic biomarker beyond GAP-43 is currently available in close enough proximity to longitudinal tau-PET assessments in open-access datasets such as ADNI, which clearly limits the study of synaptic changes in tau spreading in AD. This evidence concerns the gene GAP43 and Alzheimer disease.